New drugThe role of clopidogrel in the management of acute coronary syndromes
References (83)
- et al.
The vulnerable plaque and acute coronary syndromes
Am J Med
(2002) - et al.
Atherothrombosis: Plaque instability and thrombogenesis
Prog Cardiovasc Dis
(2002) - et al.
Platelet-active drugs: The relationships among dose, effectiveness, and side effects
Chest
(2001) - et al.
Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin
Am Heart J
(2000) - et al.
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
Am J Cardiol
(2002) - et al.
Antithrombotic therapy in patients undergoing percutaneous coronary intervention
Chest
(2001) - et al.
Subacute stent thrombosis: Evolving issues and current concepts
J Am Coll Cardiol
(1996) - et al.
Thrombotic thrombocytopenic purpura related to ticlopidine
Lancet
(1991) - et al.
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting
J Am Coll Cardiol
(2002) - et al.
Clopidogrel versus ticlopidine after intracoronary stent placement
J Am Coll Cardiol
(1999)
Clopidogrel as adjunctive antiplatelet therapy during coronary stenting
J Am Coll Cardiol
(1999)
Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting
Am J Cardiol
(1999)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study
Lancet
(2001)
The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting
J Am Coll Cardiol
(2002)
Clopidogrel and thrombotic thrombocytopenic purpura
Lancet
(2000)
Fatal aplastic anaemia associated with clopidogrel
Lancet
(2001)
Clopidogrel and aplastic anaemia
Lancet
(2001)
Statins do not affect platelet inhibition with clopidogrel during coronary stenting
Atherosclerosis
(2001)
Unstable angina pectoris
N Engl J Med
(2000)
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
Circulation
(1995)
The pathophysiology of acute coronary syndromes
Heart
(2000)
Vulnerable plaque: The pathology of unstable coronary lesions
J Intervent Cardiol
(2002)
Biologic aspects of vulnerable plaque
Curr Opin Cardiol
(2002)
Pathobiology of thrombin in acute coronary syndromes
Am Heart J
(1998)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
J Am Coll Cardiol
(2002)
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
Circulation
(1999)
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
Lancet
(1988)
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
BMJ
(2002)
Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial
N Engl J Med
(1985)
Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study
N Engl J Med
(1983)
Aspirin, heparin, or both to treat acute unstable angina
N Engl J Med
(1988)
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
N Engl J Med
(1994)
Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE Study
Lancet
(1997)
Platelet glycoprotein IIb/IIIa receptor blockade and lowdose heparin during percutaneous coronary revascularization
N Engl J Med
(1997)
Randomised placebo-controlled and balloon-angioplastycontrolled trial to assess safety of coronary stenting with use of platelet glycoproteinIIb/IIIa blockade
Lancet
(1998)
A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
N Engl J Med
(1998)
Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Qwave myocardial infarction
N Engl J Med
(1998)
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy
N Engl J Med
(1998)
Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: The ESPRIT trial: A randomized controlled trial
JAMA
(2001)
Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: A meta-analysis of phase III multicenter randomized trials
Circulation
(2001)
Cited by (0)
Copyright © 2003 Published by Elsevier Inc.